文献速递治疗药物监测与药物基因组学

英格兰NHS药物基因组学检测实施评估框架

How to assess pharmacogenomic tests for implementation in the NHS in England.
PubMed 文献 · Br J Clin Pharmacol · 2023-07-20

该研究通过检索EMBASE和Medline数据库中的前瞻性研究,结合临床咨询组意见,提炼出用于评估药物基因组学检测实施提案的10点清单,旨在为英格兰NHS提供标准化、循证的实施框架,以减少不公平和重复并集中委托检测。

要点

  • 提出了一个10点清单用于评估药物基因组学检测的实施提案。
  • 该框架基于文献综述和临床咨询组对关键主题的优先排序。
  • 建议采用国家层面方法集中委托检测以减少不公平和重复。

核心结论

  • 10点清单提供了一种标准化方法,可用于评估将药物基因组学检测纳入常规临床实践的提案。
  • 建议从英格兰NHS视角出发采用国家层面方法,以集中委托适当的检测并减少地区方法带来的不公平和重复。

研究设计与样本

  • 通过EMBASE和Medline数据库进行文献综述,识别药物基因组学检测的前瞻性研究,关注临床结局和实施。
  • 由药理学、药物基因组学、处方集评估和政策实施领域的临床咨询组审查文献数据并确定主题优先级。

主要发现

  • 文献综述和讨论提炼出10点清单,作为辅助循证实施药物基因组学检测的工具。
  • 该清单旨在为NHS常规临床 care 中实施药物基因组学检测提供标准化评估方法。

关键数值与推荐

  • 10点清单的具体条目未在摘要中列出。

临床怎么用

  • 可用于评估药物基因组学检测的实施提案,支持国家层面集中委托决策。
  • 该框架可能适用于其他卫生系统。

局限性

  • 摘要未报告文献检索的具体时间范围、纳入研究数量或清单的验证情况。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS: Pharmacogenomic testing has the potential to target medicines more effectively towards those who will benefit and avoid use in individuals at risk of harm. Health economies are actively considering how pharmacogenomic tests can be integrated into health care systems to improve use of medicines. However, one of the barriers to effective implementation is evaluation of the evidence including clinical usefulness, cost-effectiveness, and operational requirements. We sought to develop a framework that could aid the implementation of pharmacogenomic testing. We take the view from the National Health Service (NHS) in England. METHODS: We used a literature review using EMBASE and Medline databases to identify prospective studies of pharmacogenomic testing, focusing on clinical outcomes and implementation of pharmacogenomics. Using this search, we identified key themes relating to the implementation of pharmacogenomic tests. We used a clinical advisory group with expertise in pharmacology, pharmacogenomics, formulary evaluation, and policy implementation to review data from our literature review and the interpretation of these data. With the clinical advisory group, we prioritized themes and developed a framework to evaluate proposals to implement pharmacogenomics tests. RESULTS: Themes that emerged from review of the literature and subsequent discussion were distilled into a 10-point checklist that is proposed as a tool to aid evidence-based implementation of pharmacogenomic testing into routine clinical care within the NHS. CONCLUSION: Our 10-point checklist outlines a standardized approach that could be used to evaluate proposals to implement pharmacogenomic tests. We propose a national approach, taking the view of the NHS in England. Using this approach could centralize commissioning of appropriate pharmacogenomic tests, reduce inequity and duplication using regional approaches, and provide a robust and evidence-based framework for adoption. Such an approach could also be applied to other health systems.

来源:Br J Clin Pharmacol,查看原文。版权归原作者所有。

引用

  1. Sanghvi S, Ferner RE, Scourfield A, et al. How to assess pharmacogenomic tests for implementation in the NHS in England. Br J Clin Pharmacol. 2023. PMID: 37313748. doi:10.1111/bcp.15820

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。